XML 23 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation
9 Months Ended
Sep. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Based Compensation

6. Stock Based Compensation

The Company accounts for stock-based compensation granted to employees and directors, including employees stock option awards, restricted stock and restricted stock units in accordance with ASC 718, “Compensation – Stock Compensation” (“ASC 718”). Accordingly, stock-based compensation cost is measured at grant date, based on the fair value of the award, and is recognized as expense over the employee’s service period. The Company recognizes compensation expense on a ratable basis over the requisite service period of the award.

The Company values options using the Black-Scholes option pricing model. Restricted stock and time-based restricted stock units are valued at the grant date fair value of the underlying common shares. Performance-based restricted stock units with market conditions are valued using the Monte Carlo simulation model. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock. The Monte Carlo simulation model incorporates assumptions for the holding period, risk-free interest rate, stock price volatility and dividend yield.

2008 Equity Incentive Plan.

For the nine months ended September 30, 2017, the only active stock-based compensation plan was the 2008 Equity Incentive Plan (the “Incentive Plan”). The terms of awards granted during the nine months ended September 30, 2017 were consistent with those described in the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016.

On June 14, 2017, the stockholders approved an increase of 650,000 shares of Common Stock reserved for issuance under the Incentive Plan.

Summary of Stock Options

The following table summarizes information regarding activity under the Incentive Plan during the nine months ended September 30, 2017:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

Per Share

 

 

Aggregate

Intrinsic

Value

(thousands)

 

Outstanding as of December 31, 2016

 

 

470,985

 

 

$

8.69

 

 

 

 

 

Granted

 

 

465,900

 

 

$

10.05

 

 

 

 

 

Exercised

 

 

(55,752

)

 

$

5.89

 

 

 

 

 

Canceled or forfeited

 

 

(52,607

)

 

$

10.50

 

 

 

 

 

Outstanding as of September 30, 2017

 

 

828,526

 

 

$

9.53

 

 

$

601

 

 

The weighted average grant date fair value of the options granted under the Incentive Plan as calculated using the Black-Scholes option-pricing model was $3.55 and $6.37 per share for the three months ended September 30, 2017 and October 1, 2016, respectively. The weighted average grant date fair value of the options granted under the Incentive Plan as calculated using the Black-Scholes option-pricing model was $3.75 and $5.23 per share for the nine months ended September 30, 2017 and October 1, 2016, respectively.

The Company uses the Black-Scholes option-pricing model to estimate fair value of stock-based awards (options) with the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2017

 

 

October 1, 2016

 

 

September 30, 2017

 

 

October 1, 2016

 

Average risk free interest rate

 

 

1.80

%

 

 

1.03

%

 

 

1.79

%

 

 

1.10

%

Expected life (in years)

 

4.55 years

 

 

4.55 years

 

 

4.55 years

 

 

4.55 years

 

Dividend yield

 

—%

 

 

—%

 

 

—%

 

 

—%

 

Average volatility

 

 

42

%

 

 

46

%

 

 

42

%

 

 

46

%

 

Option-pricing models require the input of various subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility is based on analysis of the Company’s stock price history over a period commensurate with the expected term of the options, trading volume of the Company’s stock, look-back volatilities and Company specific events that affected volatility in a prior period. The expected term of employee stock options represents the weighted average period the stock options are expected to remain outstanding and is based on the history of exercises and cancellations on all past option grants made by the Company, the contractual term, the vesting period and the expected remaining term of the outstanding options. The risk-free interest rate is based on the U.S. Treasury interest rates whose term is consistent with the expected life of the stock options. No dividend yield is included as the Company has not issued any dividends and does not anticipate issuing any dividends in the future.

The following table shows stock-based compensation expense included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2017 and October 1, 2016:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2017

 

 

October 1, 2016

 

 

September 30, 2017

 

 

October 1, 2016

 

Cost of revenues

 

$

39

 

 

$

3

 

 

$

131

 

 

$

84

 

Research and development

 

 

104

 

 

 

39

 

 

 

215

 

 

 

90

 

Sales and marketing

 

 

59

 

 

 

38

 

 

 

238

 

 

 

119

 

General and administrative

 

 

319

 

 

 

390

 

 

 

773

 

 

 

977

 

 

 

$

521

 

 

$

470

 

 

$

1,357

 

 

$

1,270

 

 

Stock-based compensation expense capitalized to inventory was immaterial for the nine months ended September 30, 2017 and October 1, 2016.

Occasionally, the Company will grant stock-based instruments to non-employees. During the nine months ended September 30, 2017 and October 1, 2016, the amount of stock-based compensation related to non-employee options was not material.  

Information regarding stock options outstanding, vested, expected to vest, and exercisable as of September 30, 2017 is summarized below:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic Value

(thousands)

 

Options outstanding

 

 

828,526

 

 

$

9.53

 

 

 

5.45

 

 

$

601

 

Options vested and expected to vest

 

 

743,785

 

 

$

9.45

 

 

 

5.30

 

 

$

597

 

Options exercisable

 

 

272,008

 

 

$

7.94

 

 

 

3.39

 

 

$

555

 

 

The aggregate intrinsic value in the table above represents the pre-tax intrinsic value, based on the Company’s closing price as of September 30, 2017, that would have been received by option holders had all option holders exercised their stock options as of that date. This amount changes based on the fair market value of the Company’s common stock. The total intrinsic value of options exercised for the three months ended September 30, 2017 and October 1, 2016 was approximately $31 thousand and $187 thousand, respectively, and the nine months ended September 30, 2017 and October 1, 2016 was approximately $328 thousand and $735 thousand, respectively.

 

As of September 30, 2017, there was $3.9 million of total unrecognized compensation cost, net of expected forfeitures, related to non-vested stock-based compensation arrangements under the Incentive Plan. The cost is expected to be recognized over a weighted average period of 3.41 years.

Summary of Restricted Stock Units and Awards

Information regarding the restricted stock units (“RSUs”) activity for the nine months ended September 30, 2017 is summarized below:

 

 

 

Number

of Shares

 

Outstanding as of December 31, 2016

 

 

335,805

 

Restricted stock units granted

 

 

112,391

 

Restricted stock units released

 

 

(67,197

)

Restricted stock units forfeited

 

 

(30,789

)

Outstanding as of September 30, 2017

 

 

350,210

 

 

During the nine months ended September 30, 2017, the Company awarded 112,391 restricted stock units at a weighted-average grant date fair value of $11.28 per share.

RSUs granted with market conditions are valued using the Monte Carlo simulation model and compensation expense is recognized ratably during the service period even if the market condition is not satisfied. To the extent that the market condition is not met, the RSUs will not vest and will be cancelled. No RSUs with market conditions were granted during the nine months ended September 30, 2017.

RSUs granted with performance conditions are valued at the grant date fair value of the underlying common shares. The Company makes a determination regarding the probability of the performance criteria being achieved and compensation expense is recognized ratably over the vesting period, if it is expected that the performance criteria will be met.

Information regarding the RSUs granted with performance conditions activity for the nine months ended September 30, 2017 is summarized below:

 

 

 

Number

of Shares

 

Outstanding as of December 31, 2016

 

 

1,289

 

Restricted stock awards granted

 

 

4,301

 

Restricted stock awards released

 

 

(1,289

)

Outstanding as of September 30, 2017

 

 

4,301

 

 

During the nine months ended September 30, 2017, the Company awarded 4,301 RSUs granted with performance conditions at a weighted-average grant date fair value of $9.30 per share.